1 company and 1 research report found for "Acucela"
No sector reports have been found.
Acucela recently published overall encouraging Phase IIa data for its lead dry AMD compound, emixustat, which is being developed in collaboration with...
Forgotten your login?
Registered office: Edison Investment Research Limited, 280 High Holborn, London, WC1V 7EE UK. Company no. 4794244. VAT no. 815041270
© 2017 All rights reserved. Edison Investment Research is authorised and regulated by the Financial Conduct Authority.
This site requires cookies in order to give you the best user experience.
Find out more